Title |
Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
|
---|---|
Published in |
International Journal of Colorectal Disease, November 2012
|
DOI | 10.1007/s00384-012-1602-8 |
Pubmed ID | |
Authors |
Kah Hoong Chang, John P. Burke, J. Calvin Coffey |
Abstract |
Acute severe colitis affects 25 % of patients with ulcerative colitis (UC). Up to 30-40 % of these patients are resistant to intensive steroid therapy and therefore require rescue therapy to prevent emergent colectomy. Data comparing rescue therapy using infliximab and cyclosporine are limited and equivocal. This study evaluates the outcomes of UC patients receiving infliximab or cyclosporine as rescue therapy in acute severe steroid-refractory exacerbations. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 1 | 1% |
Czechia | 1 | 1% |
South Africa | 1 | 1% |
Unknown | 73 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 14% |
Student > Master | 10 | 13% |
Student > Bachelor | 9 | 12% |
Student > Postgraduate | 8 | 11% |
Other | 7 | 9% |
Other | 16 | 21% |
Unknown | 15 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 58% |
Computer Science | 3 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Engineering | 2 | 3% |
Other | 10 | 13% |
Unknown | 13 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2021.
All research outputs
#6,916,772
of 22,684,168 outputs
Outputs from International Journal of Colorectal Disease
#340
of 1,826 outputs
Outputs of similar age
#53,163
of 184,149 outputs
Outputs of similar age from International Journal of Colorectal Disease
#6
of 18 outputs
Altmetric has tracked 22,684,168 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,826 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.